Rhumbline Advisers Raises Stake in Oscar Health, Inc. $OSCR

Key Points

• Rhumbline Advisers increased its holdings in Oscar Health, Inc. by 6.0% during the first quarter, bringing its total ownership to 287,458 shares valued at approximately $3.77 million.
• Several institutional investors, including Vanguard Group and T. Rowe Price, also boosted their stakes in Oscar Health, with a combined institutional ownership of 75.70% of the company's stock.
• Analysts have revised their ratings on Oscar Health, with a consensus average rating of "Strong Sell" and a price target drop to $12.07.

Rhumbline Advisers boosted its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 6.0% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 287,458 shares of the company's stock after acquiring an additional 16,231 shares during the quarter. Rhumbline Advisers owned 0.11% of Oscar Health worth $3,769,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the business. Vanguard Group Inc. increased its stake in Oscar Health by 3.7% in the 1st quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company's stock worth $258,247,000 after acquiring an additional 700,469 shares during the last quarter. T. Rowe Price Investment Management Inc. increased its stake in Oscar Health by 4.1% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 11,826,245 shares of the company's stock worth $155,043,000 after acquiring an additional 467,301 shares during the last quarter. Thrive Capital Management LLC increased its stake in Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. BIT Capital GmbH increased its stake in Oscar Health by 1.1% in the 1st quarter. BIT Capital GmbH now owns 4,521,445 shares of the company's stock worth $59,276,000 after acquiring an additional 47,592 shares during the last quarter. Finally, Glynn Capital Management LLC increased its stake in Oscar Health by 14.0% in the 1st quarter. Glynn Capital Management LLC now owns 3,115,217 shares of the company's stock worth $40,840,000 after acquiring an additional 381,980 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

OSCR has been the topic of a number of research analyst reports. Wall Street Zen lowered Oscar Health from a "hold" rating to a "sell" rating in a research note on Saturday, August 9th. Barclays reduced their price objective on Oscar Health from $17.00 to $11.00 and set an "underweight" rating on the stock in a research report on Wednesday, July 23rd. Wells Fargo & Company lowered Oscar Health from an "equal weight" rating to an "underweight" rating and reduced their price objective for the company from $16.00 to $10.00 in a research report on Friday, July 11th. Raymond James Financial lowered Oscar Health from an "outperform" rating to a "market perform" rating in a research report on Tuesday, June 24th. Finally, UBS Group restated a "sell" rating and set a $11.00 price target (down from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Four investment analysts have rated the stock with a Hold rating and five have given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of "Strong Sell" and a consensus target price of $12.07.

Oscar Health Price Performance

Shares of OSCR stock opened at $19.33 on Monday. The firm has a market cap of $5.00 billion, a P/E ratio of -23.86 and a beta of 1.87. Oscar Health, Inc. has a fifty-two week low of $11.20 and a fifty-two week high of $23.79. The business's 50 day moving average price is $15.92 and its 200-day moving average price is $15.15. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, topping analysts' consensus estimates of ($0.90) by $0.01. The firm had revenue of $2.86 billion for the quarter, compared to analyst estimates of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The business's quarterly revenue was up 29.0% compared to the same quarter last year. During the same period last year, the company earned $0.20 EPS. On average, equities research analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.